TABLE 4.
Trial ID | Procedure | Phase | ASA class | N | Primary endpoint | Salt | Dose | Co-treatment | Comparator | Ref |
---|---|---|---|---|---|---|---|---|---|---|
JapicCTI111495 | Various surgeries | II | I-II | 85 | Successful anesthesia | Besylate | Induction:Various maintenance 1 mg/kg/hr | Remifentanil, rocuronium | NA | Doi (2014); Doi et al. (2015) |
NCT01937767 | Cardiac surgery | II | NA | 90 | Successful anesthesia | Besylate | Induction 6–12 mg/kg/hr; maintenance ∼1 mg/kg/hr | Fentanyl/remifentanil, rocuronium | Propofol, sevoflurane | Probst et al. (2014, 2015); Bevilacqua et al. (2015) |
JapicCTI121973 | Various surgeries | II/III | I - II | 375 | Successful anesthesia | Besylate | Induction 6–12 mg/kg/hr; maintenance ∼1 mg/kg/hr (titration) | Remifentanil, rocuronium | Propofol | Doi et al., (2020a) |
NCT03661489 | Various surgeries | III | III | 67 | Successful anesthesia | Besylate | Induction 6–12 mg/kg/hr; maintenance 2 mg/kg/hr | Remifentanil, muscle relaxant | NA | Doi et al., (2020b) |